Inhibition of induced autophagy increases apoptosis of Nara-H cells

International Journal of Oncology

Volumn 39, Issue 6, 2011, Pages 1545-1552

  Nakamura, Osamu ^a   Hitora, Toshiaki ^a   Akisue, Toshihiro ^b   Kawamoto, Teruya ^b   Yamagami, Yoshiki ^a   Yamamoto, Tetsuji ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Autophagy; mTOR; Temsirolimus

Indexed keywords

3 METHYLADENINE; MAMMALIAN TARGET OF RAPAMYCIN; TEMSIROLIMUS;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; FLUORESCENCE MICROSCOPY; MALIGNANT FIBROUS HISTIOCYTOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

APOPTOSIS; AUTOPHAGY; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; MICROSCOPY, FLUORESCENCE; ONCOGENE PROTEIN V-AKT; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; SIROLIMUS; STAINING AND LABELING; TOR SERINE-THREONINE KINASES;

EID: 80054813644     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1148     Document Type: Article

References (32)

1. Nakatani T, Marui T, Yamamoto T, et al.: Expression of stem cell factor and c-kit in human malignant fibrous histiocytoma cell line (TNMY1). Anticancer Res 23: 2329-2333, 2003. (Pubitemid 36897099)
2. Kawamoto T, Akisue T, Kishimoto K, et al.: Inhibition of PKCalpha activation in human bone and soft tissue sarcoma cells by the selective PKC inhibitor PKC412. Anticancer Res 28: 825-832, 2008. (Pubitemid 351578926)
3. Wan X and Helman LJ: The biology behind mTOR inhibition in sarcoma. Oncologist 12: 1007-1018, 2007. (Pubitemid 47359144)
4. Hay N and Sonenberg N: Upstream and downstream of mTOR. Genes Dev 18: 1926-1945, 2004. (Pubitemid 39071573)
5. Gridelli C, Maione P and Rossi A: The potential role of mTOR inhibitors in non-small cell lung cancer. Oncologist 13: 139-147, 2008. (Pubitemid 351342577)
6. Mita MM and Tolcher AW: The role of mTOR inhibitors for treatment of sarcomas. Curr Oncol Rep 9: 316-322, 2007. (Pubitemid 47045166)
7. Ito D, Fujimoto K, Mori T, et al.: In vivo antitumor effect of the mTOR inhibitor CCI-779 and gemcitabine in xenograft models of human pancreatic cancer. Int J Cancer 118: 2337-2343, 2006.
8. Easton JB and Houghton PJ: mTOR and cancer therapy. Oncogene 25: 6436-6446, 2006. (Pubitemid 44582287)
9. Kim KW, Mutter RW, Cao C, et al.: Autophagy for cancer therapy through inhibition of pro-apoptotic proteins and mammalian target of rapamycin signaling. J Biol Chem 281: 36883-36890, 2006. (Pubitemid 46042156)
10. Hung JY, Hsu YL, Li CT, et al.: 6-Shogaol, an active constituent of dietary ginger, induces autophagy by inhibiting the AKT/ mTOR pathway in human non-small cell lung cancer A549 cells. J Agric Food Chem 57: 9809-9816, 2009.
11. Tan ML, Ooi JP, Ismail N, Moad AI and Muhammad TS: Programmed cell death pathways and current antitumor targets. Pharm Res 26: 1547-1560, 2009.
12. Amaravadi RK and Thompson CB: The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin Cancer Res 13: 7271-7279, 2007.
13. Pattingre S, Espert L, Biard-Piechaczyk M and Codogno P: Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie 90: 313-323, 2008. (Pubitemid 351181247)
14. Liu D, Yang Y, Liu Q and Wang J: Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells. Med Oncol (In press).
15. Kanematsu S, Uehara N, Miki H, et al.: Autophagy inhibition enhances sulforaphane-induced apoptosis in human breast cancer cells. Anticancer Res 30: 3381-3390, 2010.
16. Ren Y, Huang F, Liu Y, Yang Y, Jiang Q and Xu C: Autophagy inhibition through PI3K/Akt increases apoptosis by sodium selenite in NB4 cells. BMB Rep 42: 599-604, 2009.
17. Petiot A, Ogier-Denis E, Blommaart EF, Meijer AJ and Codogno P: Distinct classes of phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem 275: 992-998, 2000. (Pubitemid 30051145)
18. Kiyozuka Y, Nakagawa H, Uemura Y, et al.: Novel cell lines established from a human myxoid malignant fibrous histiocytoma arising in the uterus. Cancer Genet Cytogenet 127: 7-15, 2001. (Pubitemid 32530087)
19. Biederbick A, Kern HF and Elsasser HP: Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur J Cell Biol 66: 3-14, 1995.
20. MacKenzie AR and von Mehren M: Mechanisms of mammalian target of rapamycin inhibition in sarcoma: present and future. Expert Rev Anticancer Ther 7: 1145-1154, 2007. (Pubitemid 47365007)
21. Hartford CM and Ratain MJ: Rapamycin: something old, something new, sometimes borrowed and now renewed. Clin Pharmacol Ther 82: 381-388, 2007. (Pubitemid 47414349)
22. Albanell J, Dalmases A, Rovira A and Rojo F: mTOR signalling in human cancer. Clin Transl Oncol 9: 484-493, 2007.
23. Ma WW and Jimeno A: Temsirolimus. Drugs Today 43: 659-669, 2007. (Pubitemid 350220790)
24. Peponi E, Drakos E, Reyes G, Leventaki V, Rassidakis GZ and Medeiros LJ: Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma. Am J Pathol 169: 2171-2180, 2006. (Pubitemid 351181976)
25. Figlin RA: Mechanisms of disease: survival benefit of temsirolimus validates a role for mTOR in the management of advanced RCC. Nat Clin Pract Oncol 5: 601-609, 2008.
26. Johnsen JI, Segerstrom L, Orrego A, et al.: Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo. Oncogene 27: 2910-2922, 2008. (Pubitemid 351620441)
27. Huang S, Shu L, Dilling MB, et al.: Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1). Mol Cell 11: 1491-1501, 2003. (Pubitemid 36776536)
28. Yazbeck VY, Buglio D, Georgakis GV, et al.: Temsirolimus down-regulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma. Exp Hematol 36: 443-450, 2008. (Pubitemid 351384743)
29. Nishikawa T, Tsuno NH, Okaji Y, et al.: Inhibition of autophagy potentiates sulforaphane-induced apoptosis in human colon cancer cells. Ann Surg Oncol 17: 592-602, 2010.
30. Gimenez-Xavier P, Francisco R, Platini F, Perez R and Ambrosio S: LC3-I conversion to LC3-II does not necessarily result in complete autophagy. Int J Mol Med 22: 781-785, 2008.
31. Klionsky DJ and Emr SD: Autophagy as a regulated pathway of cellular degradation. Science 290: 1717-1721, 2000. (Pubitemid 32004796)
32. Meijer AJ and Codogno P: Regulation and role of autophagy in mammalian cells. Int J Biochem Cell Biol 36: 2445-2462, 2004. (Pubitemid 39119758)